Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
HDAC inhibitor, RNA splicing modulator.
β-lactam; transpeptidase inhibitor.
Isoflavone, phytoestrogen found in soy; ER agon...
Oltipraz analog, salivary gland secretion enhan...
Endogenous opioid peptide; μOR agonist.
VEGFR1/2/3, c-Kit, PDGFR inhibitor.
Bioactive compound from olive tree.
S-adenosylmethionine nucleoside analog; methylt...
Labdane diterpene found in Andrographis; RLR (R...
D-Seco Paclitaxel is an impurity in the product...
Phenothiazine; D1/2 and α1-adrenergic antagoni...
mTORC1 inhibitor.
Endogenous glycoprotein hormone involved in red...
Thiol prodrug, antioxidant.
MEK1 inhibitor.
Impurity of omeprazole
NSAID; COX-2 inhibitor.
Endogenous peptide hormone, involved in water h...
Mycotoxin produced by species of Aspergillus; D...
Pim-1 inhibitor.